The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Thyroid Cancers MORE >>

In the absence of biological or molecular predictive markers, tumor volume doubling time is a good indicator for predicting the growth rate of papillary thyroid carcinomas during active surveillance, according to findings from a single-center cohort study recently published in Thyroid.

Latest JournalAll Journals >>

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.